Return to homepagePandemic Pact

Contribution to NordForsk's call for Nordic health data research project on COVID-19

  • Funded by The Research Council of Norway (RCN)
  • Total publications:20 publications

Grant number: 322942

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $598,617.57

  • Funder

    The Research Council of Norway (RCN)

  • Principal Investigator

    Mikael Heimonen

  • Research Location

    Norway

  • Lead Research Institution

    NORDFORSK

  • Research Priority Alignment

    N/A

  • Research Category

    14

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

20 Publications linked via Europe PMC

Last Updated:a day ago

View all publications at Europe PMC

Fluorescence polarisation activity-based protein profiling for the identification of deoxynojirimycin-type inhibitors selective for lysosomal retaining alpha- and beta-glucosidases.

1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease.

Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo.

Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections.

Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents.

An Epoxide Intermediate in Glycosidase Catalysis.

Functionalized Cyclophellitols Are Selective Glucocerebrosidase Inhibitors and Induce a Bona Fide Neuropathic Gaucher Model in Zebrafish.

Synthetic and Crystallographic Insight into Exploiting sp2 Hybridization in the Development of α-l-Fucosidase Inhibitors.

Structural and Biochemical Insights into the Function and Evolution of Sulfoquinovosidases.